(Q77397512)

English

Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HER2 status of the whole tumor

scientific article published on 01 September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HER2 status of the whole tumor (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

E Mueller-Holzner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

V Fink

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Frede

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Marth

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

69

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

13-19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11759824%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

https://scigraph.springernature.com/pub.10.1023/a:1012281221647

0 references

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of HER2 status in breast cancer: why, when and how?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of HER2 gene overexpression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous large-core breast biopsy: a multi-institutional study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Die Wertigkeit der Stanzbiopsie in der Diagnostik palpabler Brusttumoren Eine prospektive Analyse von 150 Patienten

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Image-guided core breast biopsy: a suitable method for preoperative biological characterization of small (pT1) breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

The long term prognostic significance of c-erbB-2 in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu as a predictive marker of response to breast cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

p185HER2 overexpression in human breast cancer using molecular and immunohistochemical methods

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012281221647

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77397512&oldid=1741722411"